chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pyrexia, Rash, Vaccination site inflammation
Clinical narrative: Problems to sleep because of the rash; Inflamation at the injection site; Rash in whole body; Little fever; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Problems to sleep because of the rash), VACCINATION SITE INFLAMMATION (Inflamation at the injection site), RASH (Rash in whole body) and PYREXIA (Little fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 21-Apr-2021, the patient experienced INSOMNIA (Problems to sleep because of the rash), VACCINATION SITE INFLAMMATION (Inflamation at the injection site), RASH (Rash in whole body) and PYREXIA (Little fever). At the time of the report, INSOMNIA (Problems to sleep because of the rash), VACCINATION SITE INFLAMMATION (Inflamation at the injection site), RASH (Rash in whole body) and PYREXIA (Little fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: fatigue; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and MYALGIA (Soreness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3 and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue) and MYALGIA (Soreness). At the time of the report, FATIGUE (fatigue) and MYALGIA (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medication included herbal medicine Treatment medication was not provided   This case was linked to MOD-2021-078664 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site rash
Clinical narrative: minor tiredness; Circular Rash on upper arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (minor tiredness) and VACCINATION SITE RASH (Circular Rash on upper arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014L6204) for COVID-19 vaccination.     The patient's past medical history included Swelling and Redness.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced FATIGUE (minor tiredness) and VACCINATION SITE RASH (Circular Rash on upper arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 25-Jan-2021, VACCINATION SITE RASH (Circular Rash on upper arm) had resolved. At the time of the report, FATIGUE (minor tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Added Reporter contact details, patient demographics and events were updated.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnosed with COVID virus; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Diagnosed with COVID virus) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Diagnosed with COVID virus). At the time of the report, COVID-19 (Diagnosed with COVID virus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Arm was red and warm below injection site; Arm was red and warm below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm was red and warm below injection site) and VACCINATION SITE ERYTHEMA (Arm was red and warm below injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L2A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (High Blood Pressure) since 1978 and Hypercholesterolemia (Cholesterol). Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA) for Blood pressure high, FISH OIL and MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) for Hypercholesterolemia, ACETYLSALICYLIC ACID (ASPIRIN 81) and VITAMIN D3 for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Arm was red and warm below injection site) and VACCINATION SITE ERYTHEMA (Arm was red and warm below injection site). On 22-Feb-2021, VACCINATION SITE WARMTH (Arm was red and warm below injection site) and VACCINATION SITE ERYTHEMA (Arm was red and warm below injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE WARMTH (Arm was red and warm below injection site) and VACCINATION SITE ERYTHEMA (Arm was red and warm below injection site) to be possibly related.    Treatment information was not provided.   This case was linked to MOD-2021-033610 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site reaction
Clinical narrative: Covid Arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid Arm) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid Arm) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Covid Arm) and HEADACHE (Headache) had resolved.            This case was linked to MOD-2021-020665 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Pain; get a little stiff for 1 day; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (get a little stiff for 1 day) and PAIN (Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (get a little stiff for 1 day) and PAIN (Pain). At the time of the report, MUSCULOSKELETAL STIFFNESS (get a little stiff for 1 day) had resolved and PAIN (Pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has a chronic condition.  No concomitant medications were provided.  No treatment information provided  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: TCR received on 28-May-2021, Added new event Pain.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Haemoptysis
Clinical narrative: Coughing blood; Nosebleed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HAEMOPTYSIS (Coughing blood) and EPISTAXIS (Nosebleed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HAEMOPTYSIS (Coughing blood) and EPISTAXIS (Nosebleed). At the time of the report, HAEMOPTYSIS (Coughing blood) and EPISTAXIS (Nosebleed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Lymphadenopathy, Malaise, Pain in extremity, Peripheral swelling
Clinical narrative: Swelling between the last joint and the finger nail, hard and painless; Blistering on toes and blistered fingure; Large rash; Fever; Very swollen and painful lymph node in the armpit of injection arm; Sore arm; Swollen arm; Malaise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), SWELLING (Swelling between the last joint and the finger nail, hard and painless) and BLISTER (Blistering on toes and blistered fingure) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), PYREXIA (Fever) and LYMPHADENOPATHY (Very swollen and painful lymph node in the armpit of injection arm). On an unknown date, the patient experienced SWELLING (Swelling between the last joint and the finger nail, hard and painless), BLISTER (Blistering on toes and blistered fingure) and RASH (Large rash). At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), PYREXIA (Fever) and LYMPHADENOPATHY (Very swollen and painful lymph node in the armpit of injection arm) had resolved and SWELLING (Swelling between the last joint and the finger nail, hard and painless), BLISTER (Blistering on toes and blistered fingure) and RASH (Large rash) outcome was unknown.            Concomitant medications were not provided. Treatment information included over the counter cortisone. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-020191 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swelling
Clinical narrative: Swelling between the last joint and the finger nail, hard and painless; Blistering on toes and blistered fingure; Large rash; Fever; Very swollen and painful lymph node in the armpit of injection arm; Sore arm; Swollen arm; Malaise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), SWELLING (Swelling between the last joint and the finger nail, hard and painless) and BLISTER (Blistering on toes and blistered fingure) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), PYREXIA (Fever) and LYMPHADENOPATHY (Very swollen and painful lymph node in the armpit of injection arm). On an unknown date, the patient experienced SWELLING (Swelling between the last joint and the finger nail, hard and painless), BLISTER (Blistering on toes and blistered fingure) and RASH (Large rash). At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Swollen arm), MALAISE (Malaise), PYREXIA (Fever) and LYMPHADENOPATHY (Very swollen and painful lymph node in the armpit of injection arm) had resolved and SWELLING (Swelling between the last joint and the finger nail, hard and painless), BLISTER (Blistering on toes and blistered fingure) and RASH (Large rash) outcome was unknown.            Concomitant medications were not provided. Treatment information included over the counter cortisone. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-020191 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Condition aggravated, Diplopia, Dizziness, Fatigue
Clinical narrative: Fatigue; Dizziness; Double vision; could not get out of bed; Vision changes; right eye pulls inward and becomes crossed; drastically changed her quality of life; sick; Head pain; Nausea,horrible nausea; symptoms only got worse after the second shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed) and QUALITY OF LIFE DECREASED (drastically changed her quality of life) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Provided by Reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ESTROGENS CONJUGATED (PREMARIN) and PRAVASTATIN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (symptoms only got worse after the second shot). On 05-Mar-2021, the patient experienced DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain) and NAUSEA (Nausea,horrible nausea). On an unknown date, the patient experienced FATIGUE (Fatigue) and DIZZINESS (Dizziness). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 1 dosage form; HYDROMORPHONE HYDROCHLORIDE (DILAUDID) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain), NAUSEA (Nausea,horrible nausea), FATIGUE (Fatigue), DIZZINESS (Dizziness) and CONDITION AGGRAVATED (symptoms only got worse after the second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was unknown   This case was linked to MOD-2021-022364 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Significant follow up On 30-May-2021: No specific follow-up information recorded. On 01-Jun-2021: Significant follow up
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Nausea, Quality of life decreased, Strabismus
Clinical narrative: Fatigue; Dizziness; Double vision; could not get out of bed; Vision changes; right eye pulls inward and becomes crossed; drastically changed her quality of life; sick; Head pain; Nausea,horrible nausea; symptoms only got worse after the second shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed) and QUALITY OF LIFE DECREASED (drastically changed her quality of life) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Provided by Reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ESTROGENS CONJUGATED (PREMARIN) and PRAVASTATIN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (symptoms only got worse after the second shot). On 05-Mar-2021, the patient experienced DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain) and NAUSEA (Nausea,horrible nausea). On an unknown date, the patient experienced FATIGUE (Fatigue) and DIZZINESS (Dizziness). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 1 dosage form; HYDROMORPHONE HYDROCHLORIDE (DILAUDID) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain), NAUSEA (Nausea,horrible nausea), FATIGUE (Fatigue), DIZZINESS (Dizziness) and CONDITION AGGRAVATED (symptoms only got worse after the second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was unknown   This case was linked to MOD-2021-022364 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Significant follow up On 30-May-2021: No specific follow-up information recorded. On 01-Jun-2021: Significant follow up
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Fatigue; Dizziness; Double vision; could not get out of bed; Vision changes; right eye pulls inward and becomes crossed; drastically changed her quality of life; sick; Head pain; Nausea,horrible nausea; symptoms only got worse after the second shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed) and QUALITY OF LIFE DECREASED (drastically changed her quality of life) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Provided by Reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ESTROGENS CONJUGATED (PREMARIN) and PRAVASTATIN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (symptoms only got worse after the second shot). On 05-Mar-2021, the patient experienced DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain) and NAUSEA (Nausea,horrible nausea). On an unknown date, the patient experienced FATIGUE (Fatigue) and DIZZINESS (Dizziness). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 1 dosage form; HYDROMORPHONE HYDROCHLORIDE (DILAUDID) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, DIPLOPIA (Double vision), BEDRIDDEN (could not get out of bed), VISUAL IMPAIRMENT (Vision changes), STRABISMUS (right eye pulls inward and becomes crossed), QUALITY OF LIFE DECREASED (drastically changed her quality of life), ILLNESS (sick), HEADACHE (Head pain), NAUSEA (Nausea,horrible nausea), FATIGUE (Fatigue), DIZZINESS (Dizziness) and CONDITION AGGRAVATED (symptoms only got worse after the second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was unknown   This case was linked to MOD-2021-022364 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Significant follow up On 30-May-2021: No specific follow-up information recorded. On 01-Jun-2021: Significant follow up
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Photosensitivity reaction, Vomiting
Clinical narrative: he was dizzy; can not stand in sun.; Throwing up 8 times from morning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (he was dizzy), PHOTOSENSITIVITY REACTION (can not stand in sun.) and VOMITING (Throwing up 8 times from morning) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (he was dizzy), PHOTOSENSITIVITY REACTION (can not stand in sun.) and VOMITING (Throwing up 8 times from morning). At the time of the report, DIZZINESS (he was dizzy), PHOTOSENSITIVITY REACTION (can not stand in sun.) and VOMITING (Throwing up 8 times from morning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Feeling worse; Shortness of breath; I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth; Dizziness; Tiredness; Not feeling good; Body sore; Couldnt move without feeling pain; Fever; Junctions all sore; Headaches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), DIZZINESS (Dizziness) and FEELING ABNORMAL (Not feeling good) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00AC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), FEELING ABNORMAL (Not feeling good), PYREXIA (Fever), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches). On 26-Apr-2021, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth) and FATIGUE (Tiredness). On 28-Apr-2021, the patient experienced MALAISE (Feeling worse). On 24-Apr-2021, PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness), FEELING ABNORMAL (Not feeling good), MALAISE (Feeling worse), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Movement disorder, Pain, Pain in extremity
Clinical narrative: Feeling worse; Shortness of breath; I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth; Dizziness; Tiredness; Not feeling good; Body sore; Couldnt move without feeling pain; Fever; Junctions all sore; Headaches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), DIZZINESS (Dizziness) and FEELING ABNORMAL (Not feeling good) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00AC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), FEELING ABNORMAL (Not feeling good), PYREXIA (Fever), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches). On 26-Apr-2021, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth) and FATIGUE (Tiredness). On 28-Apr-2021, the patient experienced MALAISE (Feeling worse). On 24-Apr-2021, PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness), FEELING ABNORMAL (Not feeling good), MALAISE (Feeling worse), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Visual impairment
Clinical narrative: Feeling worse; Shortness of breath; I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth; Dizziness; Tiredness; Not feeling good; Body sore; Couldnt move without feeling pain; Fever; Junctions all sore; Headaches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), DIZZINESS (Dizziness) and FEELING ABNORMAL (Not feeling good) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00AC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), FEELING ABNORMAL (Not feeling good), PYREXIA (Fever), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches). On 26-Apr-2021, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth) and FATIGUE (Tiredness). On 28-Apr-2021, the patient experienced MALAISE (Feeling worse). On 24-Apr-2021, PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness), FEELING ABNORMAL (Not feeling good), MALAISE (Feeling worse), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: started experiencing tingling in both hands and feet; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (started experiencing tingling in both hands and feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included Tingling in November 2020.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PARAESTHESIA (started experiencing tingling in both hands and feet). At the time of the report, PARAESTHESIA (started experiencing tingling in both hands and feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medications were provided No  Concomitant medications were provided
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose not administered with 36 days; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided No treatment product information was provided
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity, Presyncope, Vertigo
Clinical narrative: sore arm; nearly passed from being dizzy / daily boughts of dizziness; daily bought of s dizziness and vertigo; when driving patient feels like she is about to faint; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), DIZZINESS (nearly passed from being dizzy / daily boughts of dizziness), VERTIGO (daily bought of s dizziness and vertigo), PRESYNCOPE (when driving patient feels like she is about to faint) and NAUSEA (nausea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), DIZZINESS (nearly passed from being dizzy / daily boughts of dizziness), VERTIGO (daily bought of s dizziness and vertigo), PRESYNCOPE (when driving patient feels like she is about to faint) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (sore arm), DIZZINESS (nearly passed from being dizzy / daily boughts of dizziness), VERTIGO (daily bought of s dizziness and vertigo), PRESYNCOPE (when driving patient feels like she is about to faint) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information provided.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed dose) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     Concomitant medication was not provided. Treatment information was not provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Hypoaesthesia, Magnetic resonance imaging, Pain in extremity
Clinical narrative: arm is numb from the middle finger up, he has some feeling around his elbow; double pumped; pain in his wrist which sends an electric shock up his arm; lump/small knot; can barely lay in bed; left arm and shoulder is sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed), PAIN IN EXTREMITY (left arm and shoulder is sore), HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed) and PAIN IN EXTREMITY (left arm and shoulder is sore). On an unknown date, the patient experienced HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) and ARTHRALGIA (pain in his wrist which sends an electric shock up his arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed), PAIN IN EXTREMITY (left arm and shoulder is sore), HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow) and ARTHRALGIA (pain in his wrist which sends an electric shock up his arm) outcome was unknown and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: inconclusive (Inconclusive) Inconclusive. On an unknown date, X-ray: inconclusive (Inconclusive) Inconclusive.         This case was linked to MOD-2021-093925 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Significant Follow up appended included Lab test X-ray and MRI added. New Events Numbness in hand, Wrong technique in drug usage process and Wrist pain were added.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass, Wrong technique in product usage process, X-ray
Clinical narrative: arm is numb from the middle finger up, he has some feeling around his elbow; double pumped; pain in his wrist which sends an electric shock up his arm; lump/small knot; can barely lay in bed; left arm and shoulder is sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed), PAIN IN EXTREMITY (left arm and shoulder is sore), HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed) and PAIN IN EXTREMITY (left arm and shoulder is sore). On an unknown date, the patient experienced HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) and ARTHRALGIA (pain in his wrist which sends an electric shock up his arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (lump/small knot), ASTHENIA (can barely lay in bed), PAIN IN EXTREMITY (left arm and shoulder is sore), HYPOAESTHESIA (arm is numb from the middle finger up, he has some feeling around his elbow) and ARTHRALGIA (pain in his wrist which sends an electric shock up his arm) outcome was unknown and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (double pumped) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: inconclusive (Inconclusive) Inconclusive. On an unknown date, X-ray: inconclusive (Inconclusive) Inconclusive.         This case was linked to MOD-2021-093925 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Significant Follow up appended included Lab test X-ray and MRI added. New Events Numbness in hand, Wrong technique in drug usage process and Wrist pain were added.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Dyspnoea, Injection site erythema, Pyrexia
Clinical narrative: a terrible pain in my left breast; red target after the first shot; intense heat right after the shot; shortness of the breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of the breath), BREAST PAIN (a terrible pain in my left breast), INJECTION SITE ERYTHEMA (red target after the first shot) and PYREXIA (intense heat right after the shot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced DYSPNOEA (shortness of the breath), INJECTION SITE ERYTHEMA (red target after the first shot) and PYREXIA (intense heat right after the shot). On 01-Apr-2021, the patient experienced BREAST PAIN (a terrible pain in my left breast). At the time of the report, DYSPNOEA (shortness of the breath), INJECTION SITE ERYTHEMA (red target after the first shot) and PYREXIA (intense heat right after the shot) had resolved and BREAST PAIN (a terrible pain in my left breast) outcome was unknown.            No concomitant and treatment medications were reported
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Feeding disorder
Clinical narrative: unable to eat; stomach feels like its swelling; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (unable to eat) and ABDOMINAL DISCOMFORT (stomach feels like its swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FEEDING DISORDER (unable to eat) and ABDOMINAL DISCOMFORT (stomach feels like its swelling). At the time of the report, FEEDING DISORDER (unable to eat) and ABDOMINAL DISCOMFORT (stomach feels like its swelling) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Rash
Clinical narrative: eczema; rash under my breast; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash under my breast) and ECZEMA (eczema) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced RASH (rash under my breast). On an unknown date, the patient experienced ECZEMA (eczema). At the time of the report, RASH (rash under my breast) and ECZEMA (eczema) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Pain in extremity, Paraesthesia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness and asthenia (weak) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 017B21A) for COVID-19 vaccination. The occurrence of additional events detailed below. Concurrent medical conditions included anxiety and depression. Concomitant products included (Prozac) fluoxetine hydrochloride for anxiety and depression. On Mar 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 31, 2021, patient experienced peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness, asthenia (weak) and fatigue (tired). On Mar 31, 2021, peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness, asthenia (weak) and fatigue (tired) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or treatment medication.